Jeffrey Berkowitz is listed as a director on 7 SEC Form D filings by 3 issuers between Jan 2018 and Oct 2026: Phantom Parent, LP (Jeffersonville, IN — industry reported as "Other" — 2024–2025; $304.9M reported sold to 21 investors), Braeburn Pharmaceuticals, Inc. (Princeton, NJ — biotechnology — 2018; $110M reported sold to 8 investors) and Click Therapeutics, Inc. (New York, NY — other health care — 2024–2026; $52.1M reported sold to 50 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 8 years. Across those companies the filings report $467M sold in total.
Listed alongside Alex Zisson (4 shared filings), Cris De Luca (4 shared filings), David Klein (4 shared filings), Lezrene Cunningham (4 shared filings), Maria Forero (4 shared filings) and 26 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jeffrey. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 SEC release listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for Jeffrey Berkowitz and found 8 differences, 3 worth asking the sponsor about: Form D filed 177 days after the first sale; Form D filed 83 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.